Global Hospital Injectable Drugs Market Research Report 2023(Status and Outlook)

Global Hospital Injectable Drugs Market Research Report 2023(Status and Outlook)



Report Overview

Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.

The Global Hospital Injectable Drugs Market Size was estimated at USD 40410.00 million in 2022 and is projected to reach USD 56107.10 million by 2029, exhibiting a CAGR of 4.80% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Hospital Injectable Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hospital Injectable Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hospital Injectable Drugs market in any manner.

Global Hospital Injectable Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Hospira (Pfizer Inc.)

Baxter

Fresenius Kabi

Sandoz (Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy’s Laboratories Ltd

Grifols

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

Otsuka

B.Braun

JW Life Science

Auromedics

Sanofi

Gland Pharma

Endo International PLC

Sichuan Kelun Pharmaceutical

Cisen Pharmaceutical

Shijiazhuang No. 4 Pharmaceutical

Shandong Hualu Pharmaceutical

CR Double-Crane

Market Segmentation (by Type)

Generic Sterile Injectables

Sterile Intravenous (IV) Solutions

Market Segmentation (by Application)

Residential

Commercial

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Hospital Injectable Drugs Market

Overview of the regional outlook of the Hospital Injectable Drugs Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hospital Injectable Drugs
1.2 Key Market Segments
1.2.1 Hospital Injectable Drugs Segment by Type
1.2.2 Hospital Injectable Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hospital Injectable Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Hospital Injectable Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Hospital Injectable Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hospital Injectable Drugs Market Competitive Landscape
3.1 Global Hospital Injectable Drugs Sales by Manufacturers (2018-2023)
3.2 Global Hospital Injectable Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hospital Injectable Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Hospital Injectable Drugs Sales Sites, Area Served, Product Type
3.6 Hospital Injectable Drugs Market Competitive Situation and Trends
3.6.1 Hospital Injectable Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hospital Injectable Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hospital Injectable Drugs Industry Chain Analysis
4.1 Hospital Injectable Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hospital Injectable Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hospital Injectable Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital Injectable Drugs Sales Market Share by Type (2018-2023)
6.3 Global Hospital Injectable Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Hospital Injectable Drugs Price by Type (2018-2023)
7 Hospital Injectable Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital Injectable Drugs Market Sales by Application (2018-2023)
7.3 Global Hospital Injectable Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Hospital Injectable Drugs Sales Growth Rate by Application (2018-2023)
8 Hospital Injectable Drugs Market Segmentation by Region
8.1 Global Hospital Injectable Drugs Sales by Region
8.1.1 Global Hospital Injectable Drugs Sales by Region
8.1.2 Global Hospital Injectable Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Hospital Injectable Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hospital Injectable Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hospital Injectable Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hospital Injectable Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hospital Injectable Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Hospira (Pfizer Inc.)
9.1.1 Hospira (Pfizer Inc.) Hospital Injectable Drugs Basic Information
9.1.2 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Overview
9.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Market Performance
9.1.4 Hospira (Pfizer Inc.) Business Overview
9.1.5 Hospira (Pfizer Inc.) Hospital Injectable Drugs SWOT Analysis
9.1.6 Hospira (Pfizer Inc.) Recent Developments
9.2 Baxter
9.2.1 Baxter Hospital Injectable Drugs Basic Information
9.2.2 Baxter Hospital Injectable Drugs Product Overview
9.2.3 Baxter Hospital Injectable Drugs Product Market Performance
9.2.4 Baxter Business Overview
9.2.5 Baxter Hospital Injectable Drugs SWOT Analysis
9.2.6 Baxter Recent Developments
9.3 Fresenius Kabi
9.3.1 Fresenius Kabi Hospital Injectable Drugs Basic Information
9.3.2 Fresenius Kabi Hospital Injectable Drugs Product Overview
9.3.3 Fresenius Kabi Hospital Injectable Drugs Product Market Performance
9.3.4 Fresenius Kabi Business Overview
9.3.5 Fresenius Kabi Hospital Injectable Drugs SWOT Analysis
9.3.6 Fresenius Kabi Recent Developments
9.4 Sandoz (Novartis)
9.4.1 Sandoz (Novartis) Hospital Injectable Drugs Basic Information
9.4.2 Sandoz (Novartis) Hospital Injectable Drugs Product Overview
9.4.3 Sandoz (Novartis) Hospital Injectable Drugs Product Market Performance
9.4.4 Sandoz (Novartis) Business Overview
9.4.5 Sandoz (Novartis) Hospital Injectable Drugs SWOT Analysis
9.4.6 Sandoz (Novartis) Recent Developments
9.5 Hikma Pharmaceuticals PLC
9.5.1 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Basic Information
9.5.2 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Overview
9.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Market Performance
9.5.4 Hikma Pharmaceuticals PLC Business Overview
9.5.5 Hikma Pharmaceuticals PLC Hospital Injectable Drugs SWOT Analysis
9.5.6 Hikma Pharmaceuticals PLC Recent Developments
9.6 Dr. Reddy’s Laboratories Ltd
9.6.1 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Basic Information
9.6.2 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Overview
9.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Market Performance
9.6.4 Dr. Reddy’s Laboratories Ltd Business Overview
9.6.5 Dr. Reddy’s Laboratories Ltd Recent Developments
9.7 Grifols
9.7.1 Grifols Hospital Injectable Drugs Basic Information
9.7.2 Grifols Hospital Injectable Drugs Product Overview
9.7.3 Grifols Hospital Injectable Drugs Product Market Performance
9.7.4 Grifols Business Overview
9.7.5 Grifols Recent Developments
9.8 Nichi-Iko Group (Sagent)
9.8.1 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Basic Information
9.8.2 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Overview
9.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Market Performance
9.8.4 Nichi-Iko Group (Sagent) Business Overview
9.8.5 Nichi-Iko Group (Sagent) Recent Developments
9.9 Teva Pharmaceutical
9.9.1 Teva Pharmaceutical Hospital Injectable Drugs Basic Information
9.9.2 Teva Pharmaceutical Hospital Injectable Drugs Product Overview
9.9.3 Teva Pharmaceutical Hospital Injectable Drugs Product Market Performance
9.9.4 Teva Pharmaceutical Business Overview
9.9.5 Teva Pharmaceutical Recent Developments
9.10 Otsuka
9.10.1 Otsuka Hospital Injectable Drugs Basic Information
9.10.2 Otsuka Hospital Injectable Drugs Product Overview
9.10.3 Otsuka Hospital Injectable Drugs Product Market Performance
9.10.4 Otsuka Business Overview
9.10.5 Otsuka Recent Developments
9.11 B.Braun
9.11.1 B.Braun Hospital Injectable Drugs Basic Information
9.11.2 B.Braun Hospital Injectable Drugs Product Overview
9.11.3 B.Braun Hospital Injectable Drugs Product Market Performance
9.11.4 B.Braun Business Overview
9.11.5 B.Braun Recent Developments
9.12 JW Life Science
9.12.1 JW Life Science Hospital Injectable Drugs Basic Information
9.12.2 JW Life Science Hospital Injectable Drugs Product Overview
9.12.3 JW Life Science Hospital Injectable Drugs Product Market Performance
9.12.4 JW Life Science Business Overview
9.12.5 JW Life Science Recent Developments
9.13 Auromedics
9.13.1 Auromedics Hospital Injectable Drugs Basic Information
9.13.2 Auromedics Hospital Injectable Drugs Product Overview
9.13.3 Auromedics Hospital Injectable Drugs Product Market Performance
9.13.4 Auromedics Business Overview
9.13.5 Auromedics Recent Developments
9.14 Sanofi
9.14.1 Sanofi Hospital Injectable Drugs Basic Information
9.14.2 Sanofi Hospital Injectable Drugs Product Overview
9.14.3 Sanofi Hospital Injectable Drugs Product Market Performance
9.14.4 Sanofi Business Overview
9.14.5 Sanofi Recent Developments
9.15 Gland Pharma
9.15.1 Gland Pharma Hospital Injectable Drugs Basic Information
9.15.2 Gland Pharma Hospital Injectable Drugs Product Overview
9.15.3 Gland Pharma Hospital Injectable Drugs Product Market Performance
9.15.4 Gland Pharma Business Overview
9.15.5 Gland Pharma Recent Developments
9.16 Endo International PLC
9.16.1 Endo International PLC Hospital Injectable Drugs Basic Information
9.16.2 Endo International PLC Hospital Injectable Drugs Product Overview
9.16.3 Endo International PLC Hospital Injectable Drugs Product Market Performance
9.16.4 Endo International PLC Business Overview
9.16.5 Endo International PLC Recent Developments
9.17 Sichuan Kelun Pharmaceutical
9.17.1 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Basic Information
9.17.2 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Overview
9.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Market Performance
9.17.4 Sichuan Kelun Pharmaceutical Business Overview
9.17.5 Sichuan Kelun Pharmaceutical Recent Developments
9.18 Cisen Pharmaceutical
9.18.1 Cisen Pharmaceutical Hospital Injectable Drugs Basic Information
9.18.2 Cisen Pharmaceutical Hospital Injectable Drugs Product Overview
9.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Product Market Performance
9.18.4 Cisen Pharmaceutical Business Overview
9.18.5 Cisen Pharmaceutical Recent Developments
9.19 Shijiazhuang No. 4 Pharmaceutical
9.19.1 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Basic Information
9.19.2 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Overview
9.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Market Performance
9.19.4 Shijiazhuang No. 4 Pharmaceutical Business Overview
9.19.5 Shijiazhuang No. 4 Pharmaceutical Recent Developments
9.20 Shandong Hualu Pharmaceutical
9.20.1 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Basic Information
9.20.2 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Overview
9.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Market Performance
9.20.4 Shandong Hualu Pharmaceutical Business Overview
9.20.5 Shandong Hualu Pharmaceutical Recent Developments
9.21 CR Double-Crane
9.21.1 CR Double-Crane Hospital Injectable Drugs Basic Information
9.21.2 CR Double-Crane Hospital Injectable Drugs Product Overview
9.21.3 CR Double-Crane Hospital Injectable Drugs Product Market Performance
9.21.4 CR Double-Crane Business Overview
9.21.5 CR Double-Crane Recent Developments
10 Hospital Injectable Drugs Market Forecast by Region
10.1 Global Hospital Injectable Drugs Market Size Forecast
10.2 Global Hospital Injectable Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hospital Injectable Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Hospital Injectable Drugs Market Size Forecast by Region
10.2.4 South America Hospital Injectable Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hospital Injectable Drugs by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Hospital Injectable Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Hospital Injectable Drugs by Type (2024-2029)
11.1.2 Global Hospital Injectable Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Hospital Injectable Drugs by Type (2024-2029)
11.2 Global Hospital Injectable Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Hospital Injectable Drugs Sales (K MT) Forecast by Application
11.2.2 Global Hospital Injectable Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings